In some cancers, such as breast cancer and hepatocellular carcinoma (HCC) the role of IFIT1 in cancer biology is controversial, with evidence somewhat skewed towards supporting its role as a favorable prognostic factor. This evidence concerns the gene IFIT1 and hepatocellular carcinoma.